<DOC>
	<DOCNO>NCT02386462</DOCNO>
	<brief_summary>Dexmedetomidine use co-induction agent facilitate laryngeal mask airway ( LMA ) insertion minimal effect respiratory function . The purpose study determine median effective dose ( ED50 ) dexmedetomidine facilitate LMA insertion anaesthesia induction propofol 2.0 mg/kg .</brief_summary>
	<brief_title>Determine ED50 Dexmedetomidine Facilitate LMA Insertion During Anaesthesia Induction</brief_title>
	<detailed_description>Dexmedetomidine highly selective α2 receptor agonist , produce sedative , anxiolytic analgesic effect without cause clinically significant respiratory depression . Dexmedetomidine also reduce propofol requirement sedation anaesthesia induction . Therefore , dexmedetomidine may useful co-induction agent facilitate LMA insertion minimal effect respiratory function . A recent study show dexmedetomidine administration prior propofol induction provide similar condition successful LMA insertion , fentanyl without respiratory depression . The purpose study determine median effective dose ( ED50 ) dexmedetomidine require successful LMA insertion induction propofol 2 mg/kg .</detailed_description>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>1 . ASA Ⅰ ~ Ⅱ woman undergo Laparoscopic surgery . 2 . Written informed consent patient relatives participate patient . 3 . BMI:18.5～25 1 . Mental illness match 2. epidural anesthesia contraindicate 3 . People Slowtype arrhythmias 4 . Chronic renal failure 5 . Alcohol drug abuse 6 . Already take gabapentin , pregabalin , benzodiazepin antidepression drug</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>laryngeal mask airway</keyword>
	<keyword>circulatory reflex</keyword>
</DOC>